Ylä-Herttuala S, Rosenfeld M E, Parthasarathy S, Sigal E, Särkioja T, Witztum J L, Steinberg D
Department of Medicine, University of California, San Diego 92093.
J Clin Invest. 1991 Apr;87(4):1146-52. doi: 10.1172/JCI115111.
Oxidatively modified low density lipoprotein (LDL) exhibits several potentially atherogenic properties, and inhibition of LDL oxidation in rabbits decreases the rate of the development of atherosclerotic lesions. In vitro studies have suggested that cellular lipoxygenases may be involved in LDL oxidation, and we have shown previously that 15-lipoxygenase and oxidized LDL are present in rabbit atherosclerotic lesions. We now report that epitopes of oxidized LDL are also found in macrophage-rich areas of human fatty streaks as well as in more advanced human atherosclerotic lesions. Using in situ hybridization and immunostaining techniques, we also report that 15-lipoxygenase mRNA and protein colocalize to the same macrophage-rich areas. Moreover, these same lesions express abundant mRNA for the acetyl LDL receptor but no detectable mRNA for the LDL receptor. We suggest that atherogenesis in human arteries may be linked to macrophage-induced oxidative modification of LDL mediated by 15-lipoxygenase, leading to subsequent enhanced macrophage uptake, partly by way of the acetyl LDL receptor.
氧化修饰的低密度脂蛋白(LDL)具有多种潜在的致动脉粥样硬化特性,在兔体内抑制LDL氧化可降低动脉粥样硬化病变的发展速度。体外研究表明,细胞脂氧合酶可能参与LDL氧化,并且我们之前已证明兔动脉粥样硬化病变中存在15-脂氧合酶和氧化LDL。我们现在报告,氧化LDL的表位也存在于人类脂肪条纹中富含巨噬细胞的区域以及更晚期的人类动脉粥样硬化病变中。使用原位杂交和免疫染色技术,我们还报告15-脂氧合酶mRNA和蛋白共定位于相同的富含巨噬细胞的区域。此外,这些相同的病变表达丰富的乙酰LDL受体mRNA,但未检测到LDL受体的mRNA。我们认为,人类动脉中的动脉粥样硬化发生可能与由15-脂氧合酶介导的巨噬细胞诱导的LDL氧化修饰有关,导致随后巨噬细胞摄取增加,部分是通过乙酰LDL受体途径。